Literature DB >> 1878597

Heterogeneity of the molecular basis of hereditary pyropoikilocytosis and hereditary elliptocytosis associated with increased levels of the spectrin alpha I/74-kilodalton tryptic peptide.

P B Floyd1, P G Gallagher, L A Valentino, M Davis, S L Marchesi, B G Forget.   

Abstract

Hereditary pyropoikilocytosis (HPP) and hereditary elliptocytosis are closely related, congenital disorders of the red blood cell usually associated with defective spectrin self-association and abnormal limited tryptic digestion of the N-terminal of domain of spectrin. Enhanced cleavage by trypsin of spectrin from affected individuals at arginyl residue 45* and lysyl residue 48* frequently yields increased amounts of an alpha 1/74-Kd fragment at the expense of the normal alpha 1/80-Kd parent fragment. Limited tryptic digestion of three unrelated individuals with HPP showed the alpha 1/74 defect. To ascertain the molecular defect responsible for the abnormality, the structure of exon 2 of the alpha-spectrin gene was examined. Genomic DNA from the subjects was amplified by the polymerase chain reaction using primers flanking exon 2. Restriction endonuclease digestion of amplified products showed the loss of the HindIII site at codons 47 and 48 in one allele of subject 1 and abolished the AhaII site at codons 27 and 28 in one allele of subjects 2 and 3. Nucleotide sequence analysis of subcloned amplified DNA from the HPP subjects showed three novel amino acid substitutions. In subject 1 (a black individual), a single base substitution (AAG----AGG) at codon position 48 changes amino acid residue lysine to arginine. In subject 2 (a white individual), a single base substitution (CGT----AGT) at codon 28 changes arginine to serine. In subject 3 (a black individual), a different base substitution at position 28 (CGT----CTT) changes arginine to leucine. These mutations occur at positions of the alpha l domain where other mutations have also been described, indicating that the normal residues at these positions play an important role in spectrin dimer self-association and thus, in membrane stability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878597

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Probing large conformational rearrangements in wild-type and mutant spectrin using structural mass spectrometry.

Authors:  Sira Sriswasdi; Sandra L Harper; Hsin-Yao Tang; Patrick G Gallagher; David W Speicher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-22       Impact factor: 11.205

2.  Molecular basis and haplotyping of the alphaII domain polymorphisms of spectrin: application to the study of hereditary elliptocytosis and pyropoikilocytosis.

Authors:  P G Gallagher; L Kotula; Y Wang; S L Marchesi; P J Curtis; D W Speicher; B G Forget
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

Authors:  P G Gallagher; W T Tse; T Coetzer; M C Lecomte; M Garbarz; H S Zarkowsky; A Baruchel; S K Ballas; D Dhermy; J Palek
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site.

Authors:  Massimiliano Gaetani; Sara Mootien; Sandra Harper; Patrick G Gallagher; David W Speicher
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

5.  Erythrocytes carrying mutations in spectrin and protein 4.1 show differing sensitivities to invasion by Plasmodium falciparum.

Authors:  C A Facer
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

6.  Mechanism of assembly of the non-covalent spectrin tetramerization domain from intrinsically disordered partners.

Authors:  Stephanie A Hill; Lee Gyan Kwa; Sarah L Shammas; Jennifer C Lee; Jane Clarke
Journal:  J Mol Biol       Date:  2013-09-17       Impact factor: 6.151

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.